About: Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1990 (uk) im September 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1990 (ast) scientific article published on 01 September 1990 (en)
publication date	wds:Q68426709-7A5C8AAF-D668-4381-A753-3E73A3AB3CD1
publication date	1990-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68426709-CA933711-5B3D-4E4A-8E30-51F66CF7F0D7
language of work or name	English
cites work	wds:Q68426709-028AD72A-A5C8-48C5-9629-0BEE85D47F9F wds:Q68426709-25568022-F556-4BFA-AB71-72C065ECEC95 wds:Q68426709-649C3E06-937C-4A7B-A158-F224772BC8CE wds:Q68426709-7560379E-1BCC-4E7E-B3C8-992AB92185A0 wds:Q68426709-86D6018E-343B-46DB-B78C-D14566D5DF89 wds:Q68426709-941A478A-0135-488E-A5C5-E461544199F4 wds:Q68426709-DEAEA227-AFCB-4AAE-8FC3-08568DB87E00
cites work	Leuprolide versus diethylstilbestrol for metastatic prostate cancer Nonparametric Estimation from Incomplete Observations A controlled trial of leuprolide with and without flutamide in prostatic carcinoma Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials. Total androgen blockade for metastatic cancer of the prostate A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate Comparability of EORTC and DAPROCA studies in advanced prostatic cancer
author name string	wds:Q68426709-2709175A-EC28-4067-A3F5-2E7B5952A0F4 wds:Q68426709-5A3B902B-C40A-4740-B821-539F1BA9728C wds:Q68426709-761657F7-7397-44C8-B12A-DB8C04CA7E9C wds:Q68426709-998C4550-ACD9-4057-89E1-34DAB4264644 wds:Q68426709-9C180329-3A98-47E5-A10D-2D66075AA00F
author name string	L Denis S Suciu P Iversen R Sylvester I Christensen
rdfs:label	Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (en) Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (nl)
skos:prefLabel	Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (en) Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (nl)
name	Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (en) Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (nl)
title	wds:Q68426709-BD321BAC-5860-486E-AFEC-58E76F51D4DE
title	Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86 (en)
page(s)	wds:Q68426709-4BE104F9-BB45-439E-A7E2-FCBCD2CE0D04
page(s)	1067-1073
instance of	wds:Q68426709-98C9DFAB-7946-4BFF-AAC1-1779387915EF
instance of	scholarly article
PubMed ID	wds:Q68426709-DA1F5516-5E12-43E0-B2A5-83C10C064BF8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2144208
PubMed ID	2144208
published in	wds:Q68426709-5D0C010F-0CDB-4CE7-829E-15C22D78C608
published in	Cancer
issue	wds:Q68426709-1757F2EA-A332-4DEF-9CDE-5B20EC1EFAE2
volume	wds:Q68426709-13C05A42-F251-4066-AE5B-C4047CF16674
issue	5 Suppl
volume	66
DOI	wds:Q68426709-4F1515AD-A1E4-4470-9867-01DC50ADE79C
DOI	http://dx.doi.org/10.1002/CNCR.1990.66.S5.1067
DOI	10.1002/CNCR.1990.66.S5.1067
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68426709
is cites work of	Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders Androgens and prostate cancer: biology, pathology and hormonal therapy GnRH receptor and apoptotic signaling Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group. Drug Therapy of Prostatic Cancer Hormonal manipulation of prostatic cancer
is cites work of	wds:Q37611249-657CD300-F34A-499A-A40A-7A1BDD7C5707 wds:Q40398462-0D1486D3-454E-4D00-A91E-1056A26B1ABD wds:Q37128861-456D5E01-CDC5-4883-B798-6F7F2B3865C9 wds:Q36972786-83C229F8-21CB-48E9-9D99-1EB75C944288 wds:Q36972988-0534A923-D8B1-4CEE-A322-8075D0D9D8BB wds:Q41579452-48448757-3B02-463E-AF72-47962282EEDB wds:Q43161627-BB5C120E-CA3C-413C-96AB-E65F500EEC5B wds:Q33861087-C9D50D00-86D3-4A06-8CDE-3B280EA02F6A wds:Q36650783-EC68CAB5-671D-48F9-9FF3-728B07F79A54 wds:Q39496255-67467F68-7626-493A-98CA-F5718CAD6CFA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software